Use of retinioc acid to treat vaginal atrophy
Patent 5352699 Issued on October 4, 1994. Estimated Expiration Date: 
November 12, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
November 12, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorAssigneeApplicationNo. 150763 filed on 11/12/1993US Classes:514/559, Ring containing514/967VAGINALExaminersPrimary: Cintins, Marianne M.Assistant: Jordan, Kimberly Attorney, Agent or FirmInternational ClassA61K 031/20AbstractA method for the treatment of vaginal atrophy in a human patient in which retinoic acid is administered topically to the patient's vagina.Other References
| |
